Prescription medications, such as raloxifene, that act like estrogen in some tissues and block it in others. Commonly prescribed for some postmenopausal women to help protect bones and lower breast cancer risk.
Not reliably: in 1,706 women taking prevention drugs, chemical marks on DNA did little to predict who developed breast cancer.
The women had a high risk of breast cancer. They were taking [Selective Estrogen Receptor Modulators](/health-pr
Jawbone damage was very rare at standard doses of bone loss medicines, with little or no clear difference between the groups compared.
Medscape reported on a study presented at a 2026 bone health meeting in Boston. It compared medicines th